Guidant to withdraw defective stents made for Europe and Japan - International Herald Tribune
Guidant announced the withdrawal of Xience heart stents from the European and Japanese markets after defects were discovered during clinical trials. The company did not disclose the nature of the defects but did note they occurred because of a production problem. They had no reports of injuries to any patients who used the stents, small metal cylinders used to prop open arteries, and they are calling this a "$15 million write-off." Guidant is currently in the process of being acquired by Bo
· Read The Full Guidant Article From No Source -->
·
Read All Guidant News Stories -->